88 related articles for article (PubMed ID: 11356999)
1. Comparison of different assays for von Willebrand factor in hemodialysis patients.
Borawski J; Pawlak K; Myśliwiec M
Haemostasis; 2000; 30(6):308-15. PubMed ID: 11356999
[TBL] [Abstract][Full Text] [Related]
2. Ristocetin-Induced Platelet Aggregation (RIPA) and RIPA Mixing Studies.
Frontroth JP; Favaloro EJ
Methods Mol Biol; 2017; 1646():473-494. PubMed ID: 28804849
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patients.
Borawski J; Pawlak K; Myśliwiec M
Nephron; 2002 Aug; 91(4):671-81. PubMed ID: 12138272
[TBL] [Abstract][Full Text] [Related]
4. Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
Nakajima Y; Nogami K; Yada K; Ogiwara K; Furukawa S; Shimonishi N; Shima M
Haemophilia; 2019 May; 25(3):e174-e179. PubMed ID: 30866149
[TBL] [Abstract][Full Text] [Related]
5. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
6. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels.
Federici AB; Canciani MT; Forza I; Mannucci PM; Marchese P; Ware J; Ruggeri ZM
Haematologica; 2004 Jan; 89(1):77-85. PubMed ID: 14754609
[TBL] [Abstract][Full Text] [Related]
7. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
Ward CM; Andrews RK; Smith AI; Berndt MC
Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
[TBL] [Abstract][Full Text] [Related]
8. Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding.
Casonato A; Pontara E; Vertolli UP; Steffan A; Durante C; De Marco L; Sartorello F; Girolami A
Clin Appl Thromb Hemost; 2001 Apr; 7(2):81-6. PubMed ID: 11292197
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
10. The mucin-like macroglycopeptide region of glycoprotein Ibalpha is required for cell adhesion to immobilized von Willebrand factor (VWF) under flow but not for static VWF binding.
Li CQ; Dong JF; López JA
Thromb Haemost; 2002 Oct; 88(4):673-7. PubMed ID: 12362242
[TBL] [Abstract][Full Text] [Related]
11. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
[TBL] [Abstract][Full Text] [Related]
12. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
13. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
[TBL] [Abstract][Full Text] [Related]
14. Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies.
Oleksowicz L; Bhagwati N; DeLeon-Fernandez M
Cancer Res; 1999 May; 59(9):2244-50. PubMed ID: 10232615
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
16. Laboratory Testing for von Willebrand Disease: The Past, Present, and Future State of Play for von Willebrand Factor Assays that Measure Platelet Binding Activity, with or without Ristocetin.
Just S
Semin Thromb Hemost; 2017 Feb; 43(1):75-91. PubMed ID: 27978590
[TBL] [Abstract][Full Text] [Related]
17. Defective interaction between von Willebrand factor and platelet glycoprotein Ib--a familial study of peripheral arterial occlusive disease.
Kauhanen P; Beer JH; Lassila R
Thromb Haemost; 1997 May; 77(5):849-55. PubMed ID: 9184391
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic truncation of glycoprotein Ib alpha weakens its interaction with von Willebrand factor and impairs cell adhesion.
Schade AJ; Arya M; Gao S; Diz-Küçükkaya R; Anvari B; McIntire LV; López JA; Dong JF
Biochemistry; 2003 Feb; 42(7):2245-51. PubMed ID: 12590614
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel flow cytometric immunobead array to quantify VWF: Ag and VWF: GPIbR and its application in acute myocardial infarction.
Yan B; Xu M; Zhao Y; Guo H; Xia L; Ruan C; Zhao Y
Eur J Haematol; 2017 Sep; 99(3):207-215. PubMed ID: 28523822
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
